Filing Details

Accession Number:
0001209191-15-050757
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-05 18:04:33
Reporting Period:
2015-06-03
Filing Date:
2015-06-05
Accepted Time:
2015-06-05 18:04:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107421 Ziopharm Oncology Inc ZIOP Services-Specialty Outpatient Facilities, Nec (8093) 841475642
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1429559 G Kevin Lafond C/O Ziopharm Oncology, Inc.
1 First Ave. Parris Bldg. #34, Navy Yard
Boston MA 02129
Vice Pres., Treasurer, & Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-03 26,666 $9.60 0 No 4 S Direct
Common Stock Acquisiton 2015-06-03 3,334 $0.80 3,334 No 4 M Direct
Common Stock Disposition 2015-06-03 3,334 $9.70 0 No 4 S Direct
Common Stock Acquisiton 2015-06-03 27,500 $2.30 27,500 No 4 M Direct
Common Stock Disposition 2015-06-03 27,500 $9.70 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-06-03 3,334 $0.00 3,334 $0.80
Common Stock Stock Option (right to buy) Disposition 2015-06-03 27,500 $0.00 27,500 $2.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-02-06 No 4 M Direct
55,000 2023-06-27 No 4 M Direct
Footnotes
  1. Fully vested.
  2. 27,500 shares vest on each of 6/27/2014, 6/27/2015 and 6/27/2016.